EV Biologics, Inc. (YECO)
OTCMKTS
· Delayed Price · Currency is USD
0.295
0.00 (0.00%)
At close: Sep 17, 2024
EV Biologics Revenue
In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%.
Revenue
9.47M
Revenue Growth
-70.48%
P/S Ratio
0.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.02M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 920.97M |
| Medexus Pharmaceuticals Inc. | 108.78M |